New Study Attempts to Interrupt Parkinson's Disease

Krainc said that this approach able to interrupt the toxic cascade of oxidized dopamine and its impact on other neurons will be able to provide a target for the development of future treatments and therapies. It is important for future studies to identify patients that are in a very early stage of the neurodegenerative process in order to test possible treatments and that is right now a very tough task.

Parkinson’s disease is one of the most difficult diseases to be diagnosed on early stages because damage usually occurs far before symptoms start showing up. Many studies, such as the one using spiral drawing as a way to know the level of severity the patient has are subject of deep research right now and determining a way to identify the existence of the disease at an early stage is a task of major importance for the community behind Parkinson’s-related studies.